FOXO4-DRI (or Proxofim) is a research peptide designed to eliminate senescent cells—cells that stop dividing but cause inflammation (SASP) and accelerate aging—by inhibiting the interaction between FOXO4 and p53.
For laboratory and research use only. Not for human or veterinary use.
